πŸ‡ΊπŸ‡Έ FDA
Patent

US 8501404

Gnaq mutations in melanoma

granted A61PA61P35/00

Quick answer

US patent 8501404 (Gnaq mutations in melanoma) held by The Regents of the University of California expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P35/00